Efficacy and Safety of Empagliflozine and Semaglutide (Once Weekly) in T2DM Patients in Shtip
Authors
Valentina Velkoska Nakova
valentina.velkovska@ugd.edu.mk
Clinical Hospital, Shtip, RN Macedonia
Faculty of medical science, University Goce Delchev, Shtip, RN Macedonia
Zoran Nakov
Faculty of medical science, University Goce Delchev, Shtip, RN Macedonia
Stojka Dokuzova
Clinical Hospital, Shtip, RN Macedonia
Tatjana Prosheva
University Clinic of Endocrinology, Diabetes and Metabolic Disease, Skopje, RN Macedonia
Brankica Krstevska
Internal Medicine Centre “Srce”, Skopje, RN Macedonia
Language: English
Page range: 71 - 77
Published on: Mar 29, 2023
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Related subjects:
© 2023 Valentina Velkoska Nakova, Zoran Nakov, Stojka Dokuzova, Tatjana Prosheva, Brankica Krstevska, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.